Dengue: Clinical Trials

3 trials for Dengue, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 terminated. 3 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 23Terminated 3

Follow Dengue: new trials by email Literature Review of Dengue trials Research Report on Dengue

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study of JNJ-64281802 for the Prevention of Dengue Infection
JNJ-64281802, Placebo - Dengue
Phase 2TerminatedJanssen Research & Development, LLC15952023-02-222025-07-31
Study of AT-752 in Patients With Dengue Infection
AT-752, Placebo - Dengue Fever
Phase 2TerminatedAtea Pharmaceuticals, Inc.212022-04-292024-03-05
A Study of JNJ-64281802 in Participants With Confirmed Dengue Fever
JNJ-64281802, Placebo - Dengue
Phase 2TerminatedJanssen Research & Development, LLC52022-01-242024-03-01

Narrower conditions

Hemorrhagic Fevers, Viral (1)  ·  Infections (1)  ·  Vector Borne Diseases (1)  ·  Virus Diseases (1)

Broader conditions

Arbovirus Infections (3)  ·  Flaviviridae Infections (3)  ·  Flavivirus Infections (3)  ·  Mosquito-Borne Diseases (3)  ·  RNA Virus Infections (3)  ·  Hemorrhagic Fevers, Viral (2)  ·  Infections (2)  ·  Vector Borne Diseases (2)  ·  Virus Diseases (2)

Interventions

AT-752 (1)

Sponsors

Janssen Research & Development, LLC (2)  ·  Atea Pharmaceuticals, Inc. (1)

Countries

Brazil (2)  ·  Colombia (2)  ·  Malaysia (2)  ·  Peru (2)  ·  Philippines (2)  ·  Thailand (2)  ·  Ecuador (1)  ·  India (1)  ·  Mexico (1)  ·  Panama (1)  ·  Puerto Rico (1)  ·  Singapore (1)  ·  Taiwan (1)  ·  Vietnam (1)

Results publications

PMID 42253092